{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T14:57:08Z","timestamp":1761058628761},"reference-count":53,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2005,12,9]],"date-time":"2005-12-09T00:00:00Z","timestamp":1134086400000},"content-version":"vor","delay-in-days":4360,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arthritis & Rheumatism"],"published-print":{"date-parts":[[1994,1]]},"DOI":"10.1002\/art.1780370102","type":"journal-article","created":{"date-parts":[[2007,2,15]],"date-time":"2007-02-15T01:04:15Z","timestamp":1171501455000},"page":"1-9","source":"Crossref","is-referenced-by-count":78,"title":["Are There Differences Among Nonsteroidal Antiinflammatory Drugs?"],"prefix":"10.1002","volume":"37","author":[{"given":"Daniel E.","family":"Furst","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,12,9]]},"reference":[{"key":"e_1_2_1_2_2","doi-asserted-by":"publisher","DOI":"10.3109\/03009748809104663"},{"key":"e_1_2_1_3_2","first-page":"9","article-title":"Mechanisms of action of NSAID","volume":"9","author":"Erikson N","year":"1988","journal-title":"Ther Drug Monit"},{"key":"e_1_2_1_4_2","volume-title":"Aspirin and other non\u2010steroidal anti\u2010inflammatory drugs, Arthritis and Allied Conditions","author":"Furst DE","year":"1993"},{"key":"e_1_2_1_5_2","volume-title":"Inflammation and possible modes of action of anti\u2010inflammatory drugs, Anti\u2010inflammatory and Anti\u2010rheumatic Drugs","author":"Kitchen EA","year":"1985"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1989.tb03423.x"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(86)90074-4"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.82.21.7227"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(84)80085-6"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00290247"},{"key":"e_1_2_1_11_2","first-page":"53","article-title":"Inhibition of in vivo leucocyte migration by NSAIDs","volume":"3","author":"Scheja A","year":"1985","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.1985.tb04454.x"},{"key":"e_1_2_1_13_2","first-page":"1253","article-title":"Clinical use of multiple nonsteroidal anti\u2010inflammatory drug preparations within individual rheumatology private practices","volume":"16","author":"Pincus T","year":"1989","journal-title":"J Rheumatol"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/18.2.119"},{"key":"e_1_2_1_15_2","first-page":"1565","article-title":"NSAID in rheumatoid arthritis: duration of use as a measure of relative value","volume":"16","author":"Luggen ME","year":"1989","journal-title":"J Rheumatol"},{"key":"e_1_2_1_16_2","first-page":"110","article-title":"A double\u2010blind crossover trial of aspirin, indomethacin and phenylbutazone in ankylosing spondylitis (abstract)","volume":"15","author":"Godfrey RG","year":"1972","journal-title":"Arthritis Rheum"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1982.103"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1988.135"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1983.tb01504.x"},{"key":"e_1_2_1_20_2","volume-title":"Variations in responses to NSAID, Therapeutic Applications of NSAIDs: Subpopulations and New Formulations","author":"Bellamy N","year":"1992"},{"key":"e_1_2_1_21_2","first-page":"130","article-title":"Correlation of serum concentrations of ibuprofen stereoisomers with clinical response in the treatment of hip and knee osteoarthritis","volume":"19","author":"Bradley JD","year":"1992","journal-title":"J Rheumatol"},{"key":"e_1_2_1_22_2","unstructured":"GressbingerG PeckWS Menzel\u2010SoglowekS BruneK:(R)\u2010flurbiprofen: isomeric ballast or active entity of the racemic compound(abstract no. 14) Third World Conference on Variability in Response to Anti\u2010Rheumatic Drugs. Singapore July22\u201324 1992"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.2165\/00003088-198712060-00002"},{"key":"e_1_2_1_24_2","first-page":"91","article-title":"Frequency of administration of short half\u2010life non\u2010steroidal anti\u2010inflammatory analgesics (NSAIDs): studies with ibuprofen","volume":"4","author":"Jamali S","year":"1986","journal-title":"Clin Exp Rheumatol"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199106133242407"},{"key":"e_1_2_1_26_2","first-page":"93","article-title":"Prodrugs: the answer to NSAID\u2010induced gastropathy","volume":"3","author":"Jeremy JY","year":"1990","journal-title":"J Drug Devel"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0163-7258(87)90072-6"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1984.tb02421.x"},{"key":"e_1_2_1_29_2","volume-title":"Clinical chronopharmacology and chronotherapeutics of NSAIDs, Therapeutic Applications of NSAIDs: Subpopulations and New Formulations","author":"Reinberg A","year":"1992"},{"key":"e_1_2_1_30_2","first-page":"689","article-title":"The optimum interval between flurbiprofen doses: scheduling for circadian rhythms in RA","volume":"4","author":"Pownall R","year":"1987","journal-title":"Br J Clin Practice"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0950-3579(88)80020-7"},{"key":"e_1_2_1_32_2","unstructured":"Hansen P Horn JR eds. All NSAID are not alike with regard to drug interactions.Drug Interaction Newsletter7:7\u201311 1987"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780360610"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-114-4-307"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(91)90118-H"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-114-4-257"},{"key":"e_1_2_1_37_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-115-10-787"},{"key":"e_1_2_1_38_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-107-4-513"},{"key":"e_1_2_1_39_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199209103271101"},{"key":"e_1_2_1_40_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-198405000-00003"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1002\/j.1875-9114.1992.tb04490.x"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198402023100502"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0272-6386(86)80110-X"},{"issue":"4","key":"e_1_2_1_44_2","first-page":"S103","article-title":"Effects of salsalate, aspirin and naproxen on plasma renin activity and platelet thromboxane synthesis (abstract)","volume":"29","author":"Ryan J","year":"1986","journal-title":"Arthritis Rheum"},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.147.9.1674"},{"key":"e_1_2_1_46_2","first-page":"229","article-title":"Hepatitis aux anti\u2010inflammatories non\u2010steroidiens","volume":"43","author":"Castol A","year":"1988","journal-title":"Therapie"},{"key":"e_1_2_1_47_2","volume-title":"NSAIDs and the liver, Therapeutic Applications of NSAIDs: Subpopulations and New Formulations","author":"Katz LM","year":"1992"},{"key":"e_1_2_1_48_2","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1001\/archinte.1982.00340200050013","article-title":"Serious adverse reactions associated with sulindac","volume":"142","author":"Park GD","year":"1982","journal-title":"Arch Intern Med"},{"key":"e_1_2_1_49_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.32.11.1381"},{"key":"e_1_2_1_50_2","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jama.1986.03380130077032","article-title":"Risks of agranulocytosis and aplastic anemia","volume":"256","author":"International Agranulocytosis and Aplastic Anemia Study Group","year":"1986","journal-title":"JAMA"},{"key":"e_1_2_1_51_2","doi-asserted-by":"publisher","DOI":"10.1177\/106002808802200927"},{"key":"e_1_2_1_52_2","first-page":"931","article-title":"Non\u2010compliance with arthritis drugs: magnitude, correlates and clinical implications","volume":"8","author":"Deyo RA","year":"1981","journal-title":"J Rheumatol"},{"key":"e_1_2_1_53_2","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/24.4.313"},{"key":"e_1_2_1_54_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.152.10.1995"}],"container-title":["Arthritis & Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fart.1780370102","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/art.1780370102","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,23]],"date-time":"2023-11-23T00:10:37Z","timestamp":1700698237000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/art.1780370102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1994,1]]},"references-count":53,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1994,1]]}},"alternative-id":["10.1002\/art.1780370102"],"URL":"https:\/\/doi.org\/10.1002\/art.1780370102","archive":["Portico"],"relation":{},"ISSN":["0004-3591","1529-0131"],"issn-type":[{"value":"0004-3591","type":"print"},{"value":"1529-0131","type":"electronic"}],"subject":[],"published":{"date-parts":[[1994,1]]}}}